Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Roger Brüggemann and Hans van der Hoeven.
Roger Brüggemann
Connection Strength
0.685
Hans van der Hoeven
  1. Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19. JAMA Netw Open. 2020 08 03; 3(8):e2017708.
    View in: PubMed
    Score: 0.224
  2. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. Elife. 2020 04 27; 9.
    View in: PubMed
    Score: 0.220
  3. Flucloxacillin Results in Suboptimal Plasma Voriconazole Concentrations. Antimicrob Agents Chemother. 2017 09; 61(9).
    View in: PubMed
    Score: 0.183
  4. Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19. J Infect Dis. 2021 04 23; 223(8):1322-1333.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.